Alzamend Neuro News

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersVaxart (NASDAQ:VXRT) shares increased by 146.7% to $1.85 during Thursday's after-market session. The market value of their outstanding shares is at $327.1 million. Venus Concept (NASDAQ:VERO) s

BenzingaJun 13 16:31 ET

Alzamend Neuro Files to Sell 125M Shares of Common Stock for Holders

Seeking AlphaJun 3 16:37 ET

Express News | Alzamend Neuro Files Prospectus Related to Resale of up to 125 Mln Shares of Common Stock, of Co by Orchid Finance LLC - SEC Filing

ReutersJun 3 16:32 ET

Nasdaq Hearings Panel Granted Alzamend's Request To Continue Its Listing, Subject To Alzamend Demonstrating Compliance, On Or Before September 23, 2024

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disor

BenzingaMay 22 08:09 ET

Express News | Alzamend Neuro Announces Favorable Decision From Nasdaq Hearings Panel

ReutersMay 22 08:02 ET

Alzamend Neuro Unveils Updated Investor Presentation Outlook

TipRanksMay 15 16:55 ET

Express News | Alzamend Neuro Inc: Expects to Use Proceeds to Further Its Clinical Trials and Working Capital Purposes

ReutersMay 14 08:05 ET

Express News | Alzamend Neuro Inc: Investor Had Agreed to Purchase up to $25 Mln of Preferred Shares

ReutersMay 14 08:05 ET

Express News | Alzamend Neuro Announces Initial Closing of Private Placement

ReutersMay 14 08:00 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23

BenzingaMay 10 08:07 ET

Alzamend Neuro Secures Strategic $25M Investment Deal

TipRanksMay 9 16:43 ET

Express News | Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

ReutersMay 9 08:00 ET

Express News | Alzamend Neuro Shares Are Trading Higher After the Company Entered Into a Securities Purchase Agreement With an Institutional Investor

BenzingaMay 9 07:47 ET

Express News | EXCLUSIVE: Alzamend Neuro Tells Benzinga Co. Announces Agreement For Registered Direct Offering And Concurrent Private Placement For An Aggregate Of Up To $25M

BenzingaMay 9 07:30 ET

Alzamend Neuro Ends ATM Offering, Issues Forward-Looking Statements

TipRanksMay 7 16:43 ET

Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide

Alzamend Neuro, Inc. (NASDAQ:ALZN) made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offering program. Shares were down nearly 12% at last check. What

BenzingaMay 7 14:30 ET

Express News | Alzamend Neuro Shares Are Trading Lower After the Company Announced the Termination Its At-the-market Equity Offering Program

BenzingaMay 7 12:28 ET

Express News | Alzamend Neuro Announces Termination of at-the-Market Equity Offering Program

ReutersMay 7 08:00 ET

12 Health Care Stocks Moving In Friday's After-Market Session

GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (

BenzingaMay 3 16:31 ET

Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying

The Dow Jones index closed higher by over 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders i

BenzingaApr 24 06:54 ET